Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Hepatitis C virus inhibitors

Hepatitis C virus inhibitors

US Patent 8143414 · Granted Mar 27, 2012

Estimated economic value: $32,337,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Imidazothiadiazole and imidazopyrazine derivatives as protease activated recepto2024
Biarylmethyl heterocycles2024
4-oxo-3,4-dihydroquinazoline compounds as inhibitors of human immunodeficiency v2022
4-oxo-3,4-dihydroquinazoline compounds as inhibitors of human immunodeficiency v2022
Biarylmethyl heterocycles2022
Salts of prodrugs of piperazine and substituted piperidine antiviral agents2022
Benzofuran derivatives for the treatment of hepatitis C2021
Inhibitors of human immunodeficiency virus replication2021
Inhibitors of human immunodeficiency virus replication2021
Imidazothiadiazole and imidazopyrazine derivatives as protease activated recepto2020
5-(n-[6,5]-fused bicyclic aryl tetrahydroisoquinolin-6-yl) pyridin-3-yl acetic a2020
Substituted benzofuran compounds for the treatment of hepatitis C2020